Research article
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
-
* Corresponding author: Richard S Finn rfinn@mednet.ucla.edu
Breast Cancer Research 2009, 11:R77 doi:10.1186/bcr2419
See related editorial by Sutherland and Musgrove, http://breast-cancer-research.com/content/11/6/112
No comments have yet been made on this article.